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ABSTRACT
The bacterial activator protein NorR binds to
enhancer-like elements, upstream of the promoter
site, and activates p
54-dependent transcription
of genes that encode nitric oxide detoxifying
enzymes (NorVW), in response to NO stress.
Unique to the norVW promoter in Escherichia coli
is the presence of three enhancer sites associated
with a binding site for p
54-RNA polymerase. Here
we show that all three sites are required for
NorR-dependent catalysis of open complex forma-
tion by p
54-RNAP holoenzyme (Ep
54). We demon-
strate that this is essentially due to the need for all
three enhancers for maximal ATPase activity of
NorR, energy from which is used to remodel the
closed Ep
54 complex and allow melting of the
promoter DNA. We also find that site-specific DNA
binding per se promotes oligomerisation but the
DNA flanking the three sites is needed to further
stabilise the functional higher order oligomer
of NorR at the enhancers.
INTRODUCTION
Nitric oxide (NO) is a highly reactive radical species
that is toxic to micro-organisms. It can be encountered
exogenously, as a consequence of pathogen invasion,
or endogenously through the process of respiratory
denitriﬁcation (1,2). Escherichia coli is known to possess
at least three enzymes capable of directly detoxifying NO,
by utilising either NO reductase or NO dioxygenase
activities (3–5). One of these systems comprises the
enzyme ﬂavorubredoxin (encoded by norV) and its
associated NADH oxidoreductase (encoded by norW),
which reduces the NO radical to nitrous oxide under
anaerobic conditions (4,6).
Immediately upstream of the norVW genes is the
divergently transcribed norR gene, which encodes an
NO sensing s
54-dependent transcriptional regulator
(7,8). This protein is essential for activating transcription
of the norVW operon and shares  40% sequence
homology with Ralstonia eutropha NorR, which is respon-
sible for the transcriptional regulation of heme b3-iron NO
reductase in response to NO (9). NorR has a modular
domain architecture typical of bacterial s
54-dependent
enhancer binding proteins (bEBPs) (10) and consists
of three key domains: an N-terminal regulatory GAF
(for cGMP-speciﬁc and cGMP-regulated cyclic nucleotide
phosphodiesterase, Anabaena Adenylyl cyclase and
E. coli transcription factor FhlA) domain containing a
mononuclear ferrous iron centre that detects NO (11,12),
a central AAA+ (for ATPase associated with various
cellular activities) domain that interacts with s
54 and
couples ATP hydrolysis to promoter DNA melting
by RNA polymerase, and a C-terminal helix-turn-helix
DNA-binding domain.
Previously we reported that E. coli NorR binds to
three sites upstream of the norV promoter that contain
inverted repeats with core consensus GT-(N7)-AC (13).
These NorR-binding sites are conserved amongst the
proteobacteria and are found upstream of genes
encoding NorV (e.g. Salmonella typhimurium), Hmp (e.g.
Pseudomonas aeruginosa) and NorA (Ralstonia eutropha).
In E. coli, integration host factor (IHF) binds to the region
upstream of norVW between the norV transcription start
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other s
54-dependent systems, the bending of DNA
induced by IHF at this location may encourage interac-
tions between NorR and s
54-RNA polymerase by DNA
looping (14,15).
bEBPs function by coupling the energy yielded from
ATP hydrolysis to the isomerisation of s
54-RNA
polymerase from the closed promoter complex to the
open promoter complex that is competent for transcrip-
tion initiation (16–18). Oligomerisation of the AAA+
domain of bEBPs to form hexameric rings is required
for the formation of a functional ATPase (19–21) but
not for ATP binding (18,22). In some cases the ATPase
activity of bEBPs is not only regulated in response to
environmental signals but is also responsive to interaction
with speciﬁc enhancers (23–25).
We previously demonstrated that the ATPase activity
of NorR is enhancer DNA-dependent in vitro (11). Here
we report that each of the three NorR enhancer sites
upstream of the norV promoter is essential for
transcriptional activation. We demonstrate that this is a
consequence of the stringent requirement for the three
enhancers for maximal ATPase activity of NorR
through promoting and stabilising a functional higher
order oligomer of the activator. We use a GAF domain
deleted form of NorR (NorRGAF), which can activate
transcription in the absence of NO, to correlate ATP
hydrolysis with higher order oligomer formation. We
also suggest that the NorR oligomer formed at the three
enhancers is stabilised by the wrapping of ﬂanking
DNA around the higher order oligomer identiﬁed in
negative-stain electron microscopy images.
MATERIALS AND METHODS
Protein puriﬁcation
E. coli NorRGAF was over-expressed and puriﬁed as
described previously (11). NorR178–452 AAA+ domain
was generated from plasmid pNorR (13) that expresses
NorR residues from 178 to 452 with a N-terminal
6-histidine tag in pET28b. The protein was puriﬁed by
nickel aﬃnity chromatography and gel ﬁltration. The
His-tag was removed by thrombin cleavage for 3h at
23 C (38). Puriﬁed proteins were stored in buﬀer contain-
ing 100mM Tris–HCl pH 8, 150mM NaCl, 4mM DTT
and 5% glycerol at  80 C. Protein concentrations were
determined by the Folin-Lowry method (26).
Construction of plasmids and site-directed mutagenesis
The pNPTfus series plasmids designed for use with lacZ
fusion experiments contain either a wild type or a
mutagenised norR/norV intergenic region cloned into the
SmaI site of pUC19 (Table 1). Mutations were generated
using a PCR based mutagenesis method (27). Wild type
constructs were PCR ampliﬁed using the external primers
only:
norRfusion (external) 50-GGCGCTGAAAACGATC
CTGG-30,
norVfusion (external) 50-TCACGCACTTCCCAGTC
ACG-30.
Mutant constructs were ampliﬁed using combinations
of the external primers and the following mutagenic
internal primers:
Site1  50-TAATGAGTAGGCAAAATGCCTATCAATC-30,
Site1+ 50-GATTGATAGGCATTTTGCCTACTCATTA-30,
Site2  50-ATCAAATGGGCGATATGCCAATATCT-30,
Site2+ 50-AGATATTGGCATATCGCCCATTTGAT-30,
Site3  50-ATCTATAGGCAAATTGCCAGTGAGGCAAAG-30,
Site3+ 50-CTTTGCCTCACTGGCAATTTGCCTATAGAT-30.
To construct lacZ fusions in the E. coli chromosome,
wild type and mutant norR-norV intergenic region con-
structs were cloned from pNPTfus series plasmids into
pRS551 (28) using EcoRI and BamHI to generate lacZ
fusions. Derivatives of pRS551 were transformed into
E. coli strain MC1000. The lacZ fusion constructs were
then crossed into phage  RS45 by homologous recombi-
nation and transferred into the MC1000 chromosome at
the phage   attachment site as described previously (28).
b-galactosidase assays
Derivatives of E. coli strain MC1000 containing either the
wild type promoter or mutant promoters upstream of the
norV-lacZ reporter (Table 1) were grown either in LB
medium aerobically or in LB medium supplemented with
1% glucose when grown anaerobically. The cultures were
grown to an OD600 of  0.6nm before being induced with
potassium nitrite to a ﬁnal concentration of 4mM.
Cultures were then grown for a further 2h to allow for
expression of the norV-lacZ promoter fusion construct.
Methylation protection footprinting
DNA fragments for footprinting reactions were prepared
as described previously (13) but using plasmids
pNPTfusV, pNPTfus1V, pNPTfus2V or pNPTfus3V.
Binding reactions were carried out in DMS buﬀer
(50mM sodium cacodylate, 1mM EDTA) with 0.5mgo f
50 end-labelled EcoRI–BamHI restriction fragments and
the indicated concentration of NorRGAF in a ﬁnal
volume of 200ml. Salmon sperm DNA 2mg was also
present in reaction. Reactions were incubated for 10min
at room temperature, then 5ml of 10% dimethyl sulphate
(Sigma, in ethanol) was added to each binding reaction
and incubation continued for a further 5min. Reactions
were stopped with 50ml of ice cold DMS stop buﬀer
(1M b-mercaptoethanol, 1.5M sodium acetate, 1mg/ml
glycogen) and the DNA was then precipitated by the
addition of 750ml of ice cold ethanol, followed by
centrifugation at 13000rpm in bench-top centrifuge.
After a wash with 0.3M sodium acetate, the DNA was
subjected to a second ethanol precipitation and then
treated with 1M piperidine (Sigma) for 30min at 100 C.
The samples were then lyophilised and subjected to two
cycles of resuspension in 20ml of sterile water followed
by further lyophilisation. After the ﬁnal lyophilisation,
10ml of formamide loading dye was added to each
Nucleic Acids Research,2010, Vol.38, No. 4 1183sample followed by resolution on a 6% polyacrylamide
sequencing gel.
Coupled ATPase activity assay
For experiments with low protein concentrations, ATPase
activity was measured using an assay in which production
of ADP is coupled to the oxidation of NADH by lactate
dehydrogenase and pyruvate kinase (29). The oxidation of
NADH was monitored at 340nm at 37 C. All reaction
mixtures contained ATP (30mM), phosphoenolpyruvate
(1mM), NADH (0.3mM), pyruvate kinase (7U, Roche),
lactate dehydrogenase (23U, Roche) in 50mM Tris–HCl
(pH 8.0), 100mM KCl, 2mM MgCl2 and 300nM of
NorRGAF. Either wild type pNPTfusV or a plasmid
carrying a mutation in one of the NorR-binding sites
were added to the reaction mixtures, since NorRGAF
ATPase activity is enhancer-DNA dependent (30).
ATPase activity was measured by observing the change
in absorbance at 340nm.
Open promoter complex and band-shift assays
Template DNA for open complex assays was obtained
by digesting the plasmid pNPTfusV, pNPTfus1V,
pNPTfus2V or pNPTfus3V with EcoRI and BamHI to
yield a DNA fragment including the norVW promoter
and upstream activator sequences. The DNA fragments
were 50 end-labelled with
32P as described above for use
in gel retardation and DNA footprinting assays.
Open complex formation was assayed in TAP buﬀer
(50mM Tris–acetate, 100mM potassium acetate,
8mM magnesium acetate, 3.5% polyethylene glycol
8000, 1mM DTT, pH 7.9) and contained 1nM template
DNA, 200nM core RNA polymerase (Epicentre
Biotechnologies), 200nM s
54, 130nM IHF, 5mM ATP
and 0.5mM CTP. The reaction components were
pre-incubated for 10min at 30 C, and reactions were
initiated by adding NorRGAF to a ﬁnal concentration
of between 115 and 460nM. After a further 20min incu-
bation at 30 C, samples were mixed with 3ml of dye
mixture containing 50% glycerol, 0.05% bromophenol
blue, 0.1% xylene cyanol and 2mg of heparin and imme-
diately loaded onto a 4% (wt/vol) polyacrylamide gel
(acrylamide/bisacrylamide ratio, 80:1) in 25mM Tris–
400mM glycine, pH 8.6, which had been pre-run at
180V at room temperature down to a constant power of
2W. Gels were run at 150V and were dried and exposed
to autoradiograph ﬁlm or a phosphorimager screen.
NorRGAF-DNA band-shift experiments were carried
out using either a
32P labelled 266bp PCR product
(primer norvfus 50-GGCGCTGAAAACGATCCTGG-30
and primer norRpromR 50-GGTTGACCAACCCAATG
AATG-30) or a 66bp fragment generated by hybridisation
of oligonucleotide primers spanning the NorR-binding
region (50-TCACTGTCAATTTGACTATAGATATTGT
CATATCGACCATTTGATTGATAGTCATTTTGACT
ACTC-30 and its reverse complemented partner).
Reactions were prepared in the same way as for the
open complex assay but with NorRGAF and DNA
only in TAP buﬀer. The same dilution series of a fresh
preparation of NorRGAF was used for both experi-
ments, which were run at the same time. Gels were
quantiﬁed with a Fujix BAS1000 phosphorimager and
the data was plotted using Graphpad Prism as described
previously (13).
Radioactive ATPase activity assay
Reactions were performed in a 10ml ﬁnal volume in
ATPase buﬀer (50mM Tris–HCl pH 8.0, 50mM NaCl,
15mM MgCl2, 0.01mM DTT) and diﬀerent concentra-
tions of NorRGAF in complex with DNA, where
indicated. The mix was preincubated at 23 C for 10min
and the reaction was started by adding 3ml of an ATP
mixture [1mM ATP and 0.6mCi/mlo f[ a-
32P]ATP
(3000Ci/mmol)] and incubated for diﬀerent times
Table 1. Strains and plasmids
Description Reference/source
Plasmid
pRS551 Vector for construction of lacZ promoter fusions. (28)
pNorR Derivative of pET21a expressing norR (13)
pNPTfusV pUC19 carrying the norRV intergenic region for norV promoter fusions This work
pNPTfus1V As pNPTfusV but NorR site 1 mutated to GG(N7)CC This work
pNPTfus2V As pNPTfusV but NorR site 2 mutated to GG(N7)CC This work
pNPTfus3V As pNPTfusV but NorR site 3 mutated to GG(N7)CC This work
pRS551-wtV Fusion vector constructed from pNPTfusV This work
pRS551-1V Fusion vector constructed from pNPTfus1V This work
pRS551-2V Fusion vector constructed from pNPTfus2V This work
pRS551-3V Fusion vector constructed from pNPTfus3V This work
Strain
DH10B mcrA (mrr-hsdRMS-mcrBC) u80lacZM15 lacX74 recA1 endA1 araD139
(ara, leu)7697 galU galK  - rpsL nupG
Invitrogen
MC1000 araD139  (araABC-leu)7679 galU galK (lac)X74 rpsL (44)
MH1003 DH10B norR::cat  norV-lacZ (7)
MC100V MC1000  norV-lacZ This work
MC101V MC1000  norV-lacZ NorR site 1 mutant This work
MC102V MC1000  norV-lacZ NorR site 2 mutant This work
MC103V MC1000  norV-lacZ NorR site 3 mutant This work
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NorRGAF ATPase using double-stranded (ds) DNA
of three diﬀerent lengths (21, 66 and 266bp) containing
diﬀerent regions of the norR-norV intergenic region.
The 21bp fragment was generated by hybridisation
of oligonucleotide primers spanning the NorR-binding
site 1 (50-GATAGTCATTTTGACTACTCA-30 and its
reverse complemented partner). Complexes tested were
composed of diﬀerent protein to DNA molar ratios (as
indicated in ﬁgure legends). Reactions were stopped by
adding ﬁve volumes of 2M formic acid. [a-
32P]ADP was
separated from [a-
32P]ATP using thin-layer chromatogra-
phy (Polygram Cel 300 PEI). Radioactivity was detected
by PhosphorImager (Fuji Bas-5000) and quantiﬁed using
the AIDA image analyzer software, version 3.52 (Raytest,
Straubenhardt, Germany). Reactions were stopped when
 20% of total ATP was hydrolysed to ensure similar pro-
portion of ADP in all reactions. The ATPase activity
is expressed in turnover per minute for all experiments.
The curves were ﬁtted using the Origin 7.0 software
(OriginLab Corp.). All experiments were performed at
least in triplicate. Moreover, we established (data not
shown) that the rate of ATP hydrolysis was linear under
assay conditions.
Analytical gel ﬁltration
NorRGAF (at diﬀerent concentrations) was incubated
with diﬀerent DNA fragments where speciﬁed (at concen-
trations speciﬁc to the desired molar stoichiometry of the
complex) for 10min at 23 C in buﬀer containing 20mM
Tris–HCl pH 8.0, 100mM NaCl, 15mM MgCl2 and 1mM
ATP where indicated. In the presence of ATP, samples
were incubated at 4 C. Samples (100ml) were then
injected onto a Superose 6 column (10 300mm, 24ml)
(GE Healthcare) installed on an AKTA system (GE
Healthcare), which was pre-equilibrated with the sample
buﬀer. Chromatography was performed at 4 C at a ﬂow
rate of 0.5mlmin
 1, and the column was calibrated
with globular proteins: apoferritin (443kDa), alcohol
dehydrogenase (150kDa), bovine serum albumin
(66kDa) and carbonic anhydrase (29kDa). NorR178–452
(100mM) was ﬁltered through a Superdex 200 column
(10 300mm, 24ml; GE Healthcare) in the presence and
absence of 1mM ATP at 4 C. Chromatography condi-
tions were similar to that of NorRGAF.
Negative-stain electron microscopy and image processing
Two microlitre of fractions containing the NorRGAF-
266bp DNA complex eluted from the gel ﬁltration
column (elution peak at 9.3ml) was adsorbed onto
glow-discharged continuous carbon grids (TAAB) and
stained with 2% uranyl acetate. Data were collected at
50000 magniﬁcation using a Phillips CM200 FEG
electron microscope operating at 200kV. Micrographs
were recorded directly on a 4k 4k CCD camera (F415
from Tietz Video and Imaging Processing GmbH), giving
a pixel size of 1.76A ˚ . Digitised images were then
coarsened by a factor of two giving a pixel size of 3.52A ˚
per pixel. Ten-thousand particles were picked automati-
cally using the IMAGIC-5 software (31). Particles were
windowed into 128 by 128 pixel boxes, extracted and
band-pass ﬁltered between 170 and 20A ˚ . Poor-quality
particles were removed before reference free alignment
to a total sum of the dataset was carried out. Initial
class averages were generated by classiﬁcation based on
multi-variate statistical analysis (MSA). Strong class-
averages were then used as references for multi-reference
alignment (MRA) (32,33) using selected class averages as
new references. The quality of the alignment was assessed
by the class averages produced and the individual aligned
images in each class. Multiple iterations of MRA, MSA
and classiﬁcation were performed with the selected new
class-averages used as references for subsequent rounds
of MRA. Poor-quality particles were removed throughout
the alignment procedure based on alignment shifts and
visual inspection of the particles within each class. The
ﬁnal class averages were generated from 5000 particles
which were classiﬁed into 500 classes.
RESULTS
All three NorR enhancer sites are required for
activation of norV expression in vivo
In order to assess the importance of each NorR-binding
site, the enhancers were individually altered from the
consensus sequence GT-(N7)-AC to GG-(N7)-CC and
then introduced as norV-lacZ promoter fusions into the
E. coli chromosome at the phage lambda insertion site.
To activate NorR, cultures grown either under aerobic
or anaerobic conditions were treated with potassium
nitrite for 2h to induce endogenous NO production.
b-Galactosidase assays were then performed to determine
the level of norV-lacZ expression. In agreement with
previous microarray data (34) and the observation that
NorR is competent to activate transcription in the
presence of oxygen, we observed almost identical levels
of norV expression in cultures grown either in aerobic or
Figure 1. Eﬀect of NorR-binding sites on activation of a norV-lacZ
reporter. Strains MC100V, MC101V, MC102V and MC103V
(Table 1) were grown under either aerobic or anaerobic conditions
and induced with potassium nitrite (4mM). norV-lacZ expression was
then determined by measuring b-galactosidase activity. b-galactosidase
activity was minimal in MC1000 lacking a promoter fusion construct.
Nucleic Acids Research,2010, Vol.38, No. 4 1185anaerobic conditions (Figure 1). Disruption of any one of
the three NorR-binding sites was suﬃcient to completely
prevent norVW expression. Thus, all three enhancer sites
must be intact to facilitate NorR-dependent activation of
norVW transcription in vivo.
NorR binding is disrupted at mutant, but not wild type
enhancer sites in vitro
To determine the inﬂuence of the enhancer mutations on
the interaction of NorR with the promoter, methylation
protection footprinting was carried out with a 266bp
DNA fragment that contains all three NorR-binding
sites. For these experiments and all subsequent biochem-
ical assays described here, we used a truncated derivative
of NorR (NorRGAF) that retains the AAA+ and the
DNA-binding domains, but lacks the NO responsive
GAF domain. We have demonstrated previously that
NorRGAF activates norVW transcription in the
absence of NO both in vitro and in vivo (11). The
DNA-binding characteristics of NorRGAF are similar
to that of wild-type NorR (data not shown). As observed
previously, the interaction of NorR with the three
enhancer sites in the wild-type promoter was manifested
by protection and enhancement of G residues between
position  137 and  84 relative to the norV transcript
initiation site (13). In the case of the site 1 mutant, pro-
tection was observed at sites 2 and 3 but was absent at site
1 as anticipated (Figure 2B). Similarly, with either the site
2 or 3 mutant, protection by NorRGAF was lost at the
mutant site but was maintained at the two remaining wild
type enhancer sites (Figure 2C and D). However, some
methylation enhancement was detectable in most cases
at the mutant sites. If NorR binding to the three sites is
strongly co-operative it would be expected that disruption
of a single site would inﬂuence binding to the wild-type
sites. As this was not evident from the methylation pro-
tection experiments, the mutations apparently prevent
binding of NorR to each of the mutant sites, without
discernable loss of binding to the remaining wild-type
sites.
All three enhancer sites are required for stimulating the
ATPase activity of NorR"GAF
Our previous investigations have demonstrated that acti-
vation of the ATPase activity of NorR not only requires
the binding of NO to the Fe(II) centre in the GAF domain
but also requires speciﬁc DNA containing the three
enhancer sites in the norR-norV intergenic region [(11)
and data unpublished]. This suggests that in the absence
of NO, the GAF domain represses the ATPase activity of
the AAA+ domain and that binding to speciﬁc DNA
targets is also required for ATPase activation. In the
case of the truncated NorRGAF protein, the require-
ment for NO-dependent signal activation is relieved, but
the presence of DNA containing the norR-norV intergenic
region is still required for signiﬁcant ATPase activity (11).
Figure 2. Methylation protection footprinting of wild type and mutant norR-norV intergenic region constructs with NorRGAF. Footprinting
reactions contained
32P-labelled 362-bp DNA fragments from pNPTfusV series plasmids (Table 1) spanning the norR-norV intergenic region 50
end-labelled at the EcoRI end. Fragments encoded either the wild type promoter (A) or promoter constructs with NorR-binding site mutations at site
1( B), site 2 (C) or site 3 (D). NorRGAF-DNA-binding reactions were treated with dimethyl sulphate. In each case, reactions carried out in the
absence of protein are labelled ‘DNA only’. Other reactions contained between 88 and 700nM NorRGAF as indicated. Residues are numbered
relative to the norV transcript start site. Protected G residues are marked with lollipops on the left-hand side of each series. Arrows denote enhanced
methylation at G residues.
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is necessary to activate the ATPase activity of NorR.
In order to investigate the role of individual enhancer
sites in activation of the ATPase activity, we assayed ADP
release in the presence and absence of DNA fragments
carrying mutations in each of the NorR-binding sites.
In the absence of promoter DNA, NorRGAF exhibited
a low level of ATP hydrolysis (<50mM ATPmin
 1mol
 1
NorR) (Figure 3A, solid bars). This activity was
stimulated  40-fold in the presence of a DNA fragment
containing all three enhancer sites as observed previously
(11). However, the stimulation of the ATPase activity of
NorRGAF was signiﬁcantly reduced in the presence of
DNA fragments carrying mutations in each of the
NorR-binding sites (Figure 3A, open bars), and in each
case the DNA stimulation was <2-fold. These results
imply that under these conditions, at relatively low
protein concentrations (300nM), NorRGAF must be
bound to all three enhancer binding sites to catalyse
ATP hydrolysis.
Inﬂuence of NorR-binding sites on the formation of open
promoter complexes by p
54-RNA polymerase
Conformational changes in bEBPs derived from ATP
hydrolysis are coupled to the restructuring of the s
54-
RNA polymerase–promoter complex to drive the transi-
tion from closed to open complexes. In order to correlate
the eﬀects of enhancer-binding on ATP hydrolysis with
the ability of NorRGAF to remodel the s
54-RNA
polymerase, we performed open complex assays with
wild-type and mutant norV promoter DNA templates.
We assayed open promoter complex formation by
NorRGAF on wild type and mutant promoter templates
in the presence of s
54-RNA polymerase, IHF, CTP and
ATP (11) and quantiﬁed the heparin resistant species
resolved on non-denaturing polyacrylamide gels (35).
Although the binding of NorR to enhancer binding sites
is itself heparin resistant, the mobility of nucleoprotein
complexes formed upon open complex formation is con-
siderably slower and such complexes can be detected as a
super-shifted species (11). At low concentrations of
NorRGAF (115 and 230nM), open complex formation
was only observed on the DNA fragment with the three
wild type NorR enhancer sites (Figure 3B, lanes 3 and 4).
In contrast, reactions containing DNA fragments with
mutant NorR sites only exhibited open complex forma-
tion at concentrations of 460nM NorRGAF or above
(Figure 3B, lanes 10, 15 and 20). In this case, activation
may occur in trans since open complex formation is
possible in the absence of IHF at relatively high
NorRGAF concentrations (data not shown). In
control reactions carried out with 460nM NorRGAF,
but lacking the s
54 subunit, no open complex forma-
tion was observed, as expected (Figure 3B, lanes 2, 7,
12 and 17).
Super-shifted species were quantiﬁed as a percentage
of the open complexes formed at the wild type norV
promoter at 460nM NorRGAF (Figure 3C). This
analysis conﬁrmed that the level of open complexes
formed at the mutant promoter constructs was minimal
Figure 3. ATPase and open complex stimulating activities of
NorRGAF associated with wild type and mutant promoter DNA
constructs. (A) Rates of ATP hydrolysis by NorRGAF were moni-
tored at 340nm for 20min at 37 C (ﬁlled bars) after which 5nM of the
wild type norR-norVW fragment was added, and the rates were mon-
itored for a further 20min at 37 C (empty bars). ATPase activities of
NorRGAF in the presence of DNA constructs carrying a mutant
NorR-binding site were compared with the wild type construct.
ATPase activities are expressed as speciﬁc activity relative to protein
concentration in mmol ATPmin
 1mol NorR
 1. The bar representation
is a sum of the values obtained without and with DNA. (B) Each open
complex assay reaction contained 1nM of a
32P-labelled DNA
fragment encoding either the wild type or mutant norR-norVW
intergenic region. All lanes contained the components required for
open complex formation except lanes 1, 6, 11 and 16, which contained
DNA only and lanes 2, 7, 12 and 17, which contained 115nM
NorRGAF but lacked s
54. NorRGAF concentrations were
115nM (lanes 3, 8 13, 18), 230nM (lanes 4, 9, 14, 19) and 460nM
(lanes 5, 10, 15, 20). Free DNA, NorRGAF/DNA and open
complexes are indicated by the arrows to the left of the ﬁgure.
(C) Heparin resistant open complex species were quantiﬁed using
a Fujix BAS 1000 phosphorimager. Bands were quantiﬁed by their
intensity relative to the open complex band formed with the wild
type DNA construct at 460nM NorRGAF, which was assumed
to be 100%.
Nucleic Acids Research,2010, Vol.38, No. 4 1187compared to the wild type at relatively low protein con-
centrations (<200nM) but increased to 50% or less of the
wild type at 460nM NorRGAF. At this relatively high
concentration it is possible that activation of promoter
bound s
54-RNAP by NorRGAF occurs from solution
as observed with other s
54-dependent activators (17,36).
Three shifted bands (other than the super-shifted
species) were visible in reactions containing the wild type
DNA fragment (Figure 3B, lanes 2–5). These bands were
observed in the absence of IHF and s
54-RNA polymerase
(data not shown) and are presumably heparin resistant
NorR–DNA complexes. The presence of more than one
band is indicative of partial occupancy of the enhancer
sites at relatively low protein concentrations under these
buﬀer conditions. We assume that the three bands result
from the binding of NorR to one, two or all three
sites (labelled as NorR–DNA complexes A, B or C in
Figure 3B). It is notable that bands B and C were
evident in reactions carried out with the site 2 mutant
DNA fragment whereas band C was the main species
visible with fragments containing the site 1 or site 3 muta-
tions (Figure 3B, lanes 7–10, 12–15 and 17–20, respec-
tively). Therefore the latter mutations apparently
inﬂuence the binding of NorR to adjacent wild-type
enhancer sites in these heparin challenge experiments,
thus providing some evidence for cooperative binding.
NorR functions as an oligomer in vitro
The prerequisite of all three enhancer sites for maximal
ATP hydrolysis by NorR can be interpreted as the require-
ment of three functional dimers to form an active
hexamer, given the dyad axes of symmetry of the individ-
ual sites. A number of well characterised bEBPs form
hexameric ring assemblies in their active state, and this
oligomerisation itself can depend upon nucleotide (ATP
or ADP) binding or self-association at high protein con-
centrations (37). To determine if higher order oligomer
formation is necessary for NorR ATPase activity, we
assayed radioactively labelled ADP release from
[a-
32P]ATP at diﬀerent concentrations of NorRGAF.
The relationship between ATP turnover and the
NorRGAF concentration is shown in Figure 4A. We
obtained a concentration dependent sigmoidal activity
curve (Figure 4A), with a Hill coeﬃcient of 2 (Figure
4B), implying that cooperativity between monomers is
required for maximum ATPase activity of NorRGAF.
The maximum turnover (kcat), expressed in terms of
NorRGAF monomer, was 3.8min
 1, and the amount
of NorRGAF required to achieve half-maximal
ATPase activity, Keﬀ, was 12.5mM (Figure 4A).
To examine the eﬀect of physiological concentrations of
ATP on oligomer formation, we performed analytical gel
ﬁltration experiments with various concentrations of
NorRGAF in the presence and absence of 1mM ATP
at 4 C. Based on reference elution volumes obtained with
diﬀerent protein standards NorRGAF exhibited a
concentration-dependent elution proﬁle, with the dimer
form predominating at high protein concentrations
(Figure 4C, upper panel). However, in the presence of
ATP, the dimer peak broadened towards higher
oligomeric forms, independent of the protein concentra-
tion (Figure 4C, lower panel). These observations suggest
that under these conditions, ATP binding promotes self
association of NorRGAF as inferred from gel ﬁltration
proﬁle and concentration-dependent ATPase activity
(Figure 4).
Binding to a single enhancer site can stimulate NorR"GAF
ATPase activity in vitro
Our data so far demonstrate that the ATPase activity of
NorRGAF is strongly stimulated by binding to DNA
containing all three enhancer sites. This inﬂuence of DNA
on ATP hydrolysis can be either due to DNA binding
per se and/or due to increased protein concentration and
propensity for stable oligomer formation at the enhancer
sites.
To determine the eﬀects of DNA binding per se on the
state of association and ATPase activity of NorRGAF,
we used a 21bp oligonucleotide containing site 1 (NorR1),
which apparently has a stronger binding aﬃnity for
Figure 4. ATPase activity and gel ﬁltration proﬁle of NorRGAF.
(A) Plot of ATP turnover versus protein concentration, measured at
a ﬁxed concentration of ATP as substrate (1mM). (B) Log of relative
ATP hydrolysis rate V (compared to maximum rate Vmax at 47mM)
was plotted against the log of NorRGAF concentration. The slope
of the linear regression slope was used to determine the Hill coeﬃ-
cient (1.98). (C) Diﬀerent concentrations of NorRGAF were
chromatographed at 4 C (upper) or preincubated with 1mM ATP
and chromatographed in the presence of 1mM ATP at 4 C (lower).
Corresponding molecular weight of standard globular proteins were
indicated at their elution volume.
1188 Nucleic Acids Research, 2010,Vol.38, No. 4NorR than either site 2 or site 3 (13). To determine the
optimal molar ratio between NorRGAF and DNA,
ATP turnover was measured at diﬀerent protein:DNA
molar ratios while maintaining NorRGAF at 35.6mM
and ATP at 1mM (Supplementary Figure S1A, left
panel). A 1:1 molar ratio gave maximal activity and was
chosen for subsequent experiments in which we measured
ATPase activity at various NorRGAF concentrations.
In the presence of the NorR1 oligonucleotide, the ATPase
activity displayed the same sigmoidal kinetics with respect
to NorRGAF concentration (Figure 5A) while the Keﬀ
reduced from 12.5mM with NorRGAF alone to 8.4mM
in the presence of the 21bp DNA fragment (Figure 5A),
suggesting that DNA binding increases the tendency of
NorRGAF to self-associate. Interestingly, binding of
NorRGAF to the 21bp DNA fragment also increased
the kcat from 3.8 to 5.2min
 1, implying allosteric stimula-
tion of the intrinsic ATPase activity.
To conﬁrm whether binding to the 21bp oligo-
nucleotide indeed promotes self-association, we analysed
the gel ﬁltration proﬁles of NorRGAF:NorR1 com-
plexes in the presence and absence of nucleotide. The
presence of the 21bp oligonucleotide shifted the
NorRGAF associated peak towards higher molecular
mass species, independent of the presence of ATP
(Figure 5B), suggesting that binding to the single
enhancer site promotes oligomerisation, in agreement
with the increased ATPase activity observed in Figure 5A.
We next investigated if the DNA-binding domain of
NorR controls the ATPase activity of the AAA+
domain in a manner analogous to the intramolecular
repression exerted by the GAF domain. In this case the
stimulatory eﬀect on the ATPase upon DNA binding
might simply be due to the removal of this inhibition,
similar to the activation of the GAF domain by NO
binding. We compared the ATPase activity of AAA+
domain alone with that of NorRGAF under the same
protein concentrations. Interestingly, the isolated AAA+
domain of NorR had negligible ATPase activity compared
to that of NorRGAF (Figure 5C, left panel). This result
may suggest that DNA binding actively promotes ATPase
activity (probably through promoting oligomerisation of
AAA+ domain) rather than simply relieving an inhibition
imposed by the DNA-binding domain. Indeed the AAA+
domain fails to form higher order oligomers at high
concentration and in the presence of ATP (Figure 5C,
right panel).
Binding to a 66bp fragment containing three enhancer
sites (NorR123) marginally increases the ATPase
activity relative to binding to a single NorR1 site
Our data show that DNA binding per se promotes
self-association and ATPase activity. We next tested
whether availability of the three consecutive sites further
enhances the ATPase activity of NorRGAF. We used a
66bp DNA fragment (NorR123), which is the minimum
DNA length containing the three NorR-binding sites
based on previous DNA footprinting results. ATPase
activity assays were performed with increasing
NorRGAF concentrations while maintaining a 3:1
activator monomer: DNA molar stoichiometry in the
complex. This optimal DNA to protein molar stoichio-
metry was determined as described above by ﬁxing
protein and ATP concentrations and varying DNA:
protein ratios for optimal ATP turnover (Supplementary
Figure S1A, right panel). In the presence of this 66bp
DNA fragment, ATPase activity increased marginally to
a kcat of 6.8min
 1 when compared to that with the 21bp
NorR1 oligonucleotide (Figure 5A), although the Keﬀ
Figure 5. Eﬀect of individual enhancer sites on ATPase activity and
oligomerisation states of NorRGAF. (A) Comparison of the ATPase
activity of NorRGAF in the absence (cf. Fig 4A) and presence of
NorR1 or NorR123 dsDNA. A molar ratio of 1:1 and 3:1 activator
monomer: DNA was maintained for complexes formed with NorR1
and NorR123 fragments, respectively. (B) Gel ﬁltration studies of
NorRGAF (20mM) in the absence or presence of dsDNA as in
A. Complexes were also chromatographed in the presence of 1mM
ATP, with no signiﬁcant eﬀect observed on the elution proﬁle.
(C) left: ATPase activities of 26.5mM NorRGAF and NorR178–452
AAA+ domain compared. The assays were performed at 37 C, and
turnover in min
 1 was calculated when [a-
32P]ADP formed was  20 %
of total radiolabeled nucleotide. Right: the elution proﬁle of NorR
AAA+ domain (100mM) gel ﬁltered through a Superdex 200 column
in the presence and absence of 1mM ATP at 4 C. Standard globular
proteins were used for calibration: thyroglobulin (669kDa), b-amylase
(200kDa), bovine serum albumin (66kDa) and carbonic anhydrase
(29kDa).
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indicated that the complexes elute as multiple peaks
(Figure 5B), implying a highly heterogeneous population
of oligomers. Our results so far indicate that the increased
ATPase activity of NorRGAF upon binding to
enhancer DNA is largely due to DNA binding per se
rather than increased local protein concentration at the
three enhancer sites.
Binding to a 266bp DNA fragment, containing the three
enhancer sites, strongly stimulates the ATPase
activity of NorR
As stimulation of ATP hydrolysis by the 66bp oligo-
nucleotide was less than anticipated for a DNA
fragment containing all three NorR enhancer sites
(Figure 3A), we measured the ATPase activity of
NorRGAF in complex with a longer (266bp) DNA
fragment. We performed ATPase assays with this
fragment using a protein:DNA stoichoiometry of 6:1,
which was again chosen based on the optimal ATPase
activity at ﬁxed protein and ATP concentrations
(Supplementary Figure S1B). ATP turnover increased
signiﬁcantly at low protein concentrations and the Keﬀ
fell signiﬁcantly to 1.4mM when compared to that of
protein alone or in complex with the 21 and 66bp
dsDNA (Figure 6A). Furthermore, the sigmoidal nature
of the curve indicates clear evidence for cooperativity. Size
exclusion chromatography of NorRGAF in complex
with the 266bp DNA fragment revealed a signiﬁcant
shift towards a higher molecular mass species (elution
peak at 9.3ml; Figure 6B), suggesting that this DNA
fragment stabilises a higher order oligomeric form of
NorRGAF (possibly a hexamer), in contrast to the
complexes observed on the 21 and 66bp oligonucleotides
(compare Figures 5B with 6B). The presence of DNA in
the peak fraction was conﬁrmed by measuring the absorp-
tion at 280 and 260nm wavelengths. We infer from these
observations that stabilisation of a higher order oligomer
on the 266bp fragment may be responsible for the
increased stimulation of the ATPase activity of
NorRGAF.
In order to further assess the diﬀerences between the 66
and 266bp DNA, we used a gel retardation assay to
compare the aﬃnity of NorRGAF for these DNA frag-
ments. Whereas only a single shifted species was observed
on the 266bp DNA (Figure 7A), partial occupancy of
the enhancer sites was evident at low protein concentra-
tions with the 66bp DNA (Figure 7B). Quantitation of the
fully shifted species showed that NorRGAF has a 2-fold
higher aﬃnity for the 266bp DNA fragment (KD, 81nM)
compared to the 66bp DNA (KD, 174nM). Moreover, the
NorRGAF-DNA-binding curve for the 266bp DNA
fragment exhibited increased positive cooperativity with
a Hill coeﬃcient of 3.4 compared with 1.3 for the 66bp
oligonucleotide (Figure 7C). This increase in aﬃnity and
cooperativity is consistent with a more stable hexameric
ring formation, in agreement with the increased ATP
turnover observed with the longer DNA fragment
(Figure 6A). Although we cannot rule out the possibility
that the increase in aﬃnity is due to thermodynamic
requirements for DNA recognition, it is highly likely
that the aﬃnity increase is due to additional interactions
between protein and DNA, such as those encountered
through the DNA wrapping around NorR. Nevertheless,
under the conditions at which the ATPase activity and gel
ﬁltration were measured (micromolar concentrations), the
DNA should be fully saturated with protein, thus the dif-
ferences in gel ﬁltration proﬁle and ATPase activity
(Figures 5 and 6) are likely due to the diﬀerent nature of
the nucleoprotein complexes formed rather than the dif-
ferent aﬃnities for the protein–DNA interaction.
EM studies of NorR"GAF bound to 266bp
NorR123 DNA
To investigate the mechanism behind the increased
ATPase activity stimulated by the longer 266bp DNA
fragment, we analysed these protein–DNA complexes,
prepared either in situ or after puriﬁcation by gel ﬁltration
chromatography, using negatively-stained electron micro-
scopy. As shown in Figure 8B, NorRGAF does in fact
form high order oligomers in the presence of 266bp DNA.
Image analysis and classiﬁcation of 5000 particles into
class averages of 7–10 particles per class (Figure 8C)
Figure 6. The ATPase activity and oligomerisation state of
NorRGAF in the presence of the 266bp dsDNA that contains all
three enhancer sites. (A) Plot of ATP turnover versus NorRGAF
concentration in the presence of 266bp dsDNA, containing all three
enhancer sites. Activity curves are also included for comparison of
ATPase turnover at low concentrations in the presence and absence
of shorter DNA fragments. (B) Gel ﬁltration chromatography of
9mM NorRGAF in complex with 0.75mM 266bp dsDNA (a molar
ratio of 12:1 monomer: DNA) performed at 4 C using a Superose 6
column. The dotted line below the 9.3ml elution peak represents the
fractions analysed by negative-stain electron microscopy.
1190 Nucleic Acids Research, 2010,Vol.38, No. 4allowed visualisation of ring-shaped particles with dimen-
sions of 126A ˚ in diameter, consistent with a hexameric
ring observed in cryo-EM studies of other bEBPs such
as PspF1–275 and NtrC (20,38). These ring shaped particles
were not observed in the presence of the 21 or 66bp
oligonucleotides (Figure 8A), in agreement with the obser-
vations from size exclusion chromatography that the
stable higher order oligomer is only observed upon
binding of NorRGAF to the longer 266bp DNA
fragment (Figure 5B and 6B).
DISCUSSION
It has now been experimentally conﬁrmed that all
three NorR-binding sites are required for transcriptional
activation of the E. coli norV promoter. Similar conclu-
sions have been derived from deletion analysis of this
promoter (39) and also the Ralstonia eutropha norB
promoter (40). Our data extend these observations and
characterise the requirement for the three enhancers in
vitro. The presumed physiological role of bacterial
enhancers is to tether activators at high local concentra-
tion close to the promoter and to facilitate the formation
of higher oligomeric forms that are active for
transcriptional activation. While multiple enhancers are
common in s
54-dependent promoters, an absolute depen-
dency on more than one target site is unusual. For
example, two enhancers are suﬃcient to assemble higher
order oligomers of NtrC, in which some protomers are
bound by protein–protein interactions and apparently do
not contact DNA (41). In contrast, our data for NorR
indicate that all three enhancer sites are necessary for
the formation of an active oligomeric species. When
present at high concentration, bEBPs can activate tran-
scription from solution in the absence of enhancer DNA
in vitro and some s
54-dependent activators naturally lack
a DNA-binding domain (42). Moreover, in many cases the
DNA-binding domain does not appear to be essential for
transcriptional activation. For example, PspF lacking the
enhancer-binding domain (PspF1–275) can form high-order
oligomers and activate transcription in vitro.
The increased ATPase activity of NorRGAF
observed upon binding to the three enhancer sites could
be due to one or all of the following three reasons: (i)
DNA binding induces conformational changes that
promote self-association and therefore increases ATPase
activity, (ii) DNA binding stimulates ATPase activity per
se, (iii) since there are three NorR-binding sites, binding to
DNA increases the local protein concentration and thus
promotes self-association, which increases the ATPase
activity. Our data suggest that the signiﬁcant increase in
ATPase activity upon binding to enhancer sites is not
likely to be a consequence of self-association resulting
from an increase in local protein concentration. It is
more likely due to the conformational changes induced
by DNA binding that promote hexameric ring formation
and ATP hydrolysis per se, therefore increasing the
ATPase activity. Hence in the case of NorR, in addition
to GAF domain activation, the enhancer DNA sites
provide an important ligand to promote assembly of the
active oligomeric form of the activator. This is in stark
contrast to the activation mechanism of other bEBPs
such as NtrC, where activation of the receiver domain is
key to hexamer formation and ATPase activity (20). Our
results are consistent with the observation that all three
NorR-binding sites are required for catalytic activity.
Mutating any one of the sites abolishes binding of one
NorR dimer to the DNA, therefore preventing proper
hexameric ring formation. However, in the absence of
DNA, ATPase activity increases with protein concentra-
tion, in agreement with the observation that open complex
formation can be achieved in the absence of enhancer
DNA at relatively high concentrations of NorR. This
demonstrates that although the native conformation in
the absence of DNA is not optimal for formation
of higher order oligomers (as shown in gel ﬁltration
Figure 7. NorRGAF has a higher aﬃnity for the 266bp DNA
fragment than for the 66bp DNA fragment NorR123. NorRGAF
concentrations between 0 and 1000nM (as indicated above the gels)
were incubated with either the 266bp DNA fragment (A) or the
66bp DNA fragment (B). The percentage of fully shifted DNA was
quantiﬁed using a Fujix BAS 1000 phosphorimager (C).
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presence of ATP, oligomerisation can occur to enable
catalytic activity. However, the higher order complexes
formed under these conditions are likely to be far less
stable than the nucleoprotein complexes formed in the
presence of the three enhancer sites. In the absence of
the DNA-binding domain, the isolated AAA+ domain
of NorR fails to form higher order oligomers and the
Figure 8. Negative-stain electron microscopy of NorRGAF in complex with 266bp dsDNA, containing all three enhancer sites. (A) Raw
micrographs of NorRGAF in complex with 21bp NorR1 (right panel) or 66bp NorR123 (left panel) DNA fragments. Scale bar 90nm.
(B) Top, raw micrograph of NorRGAF in complex with 266bp dsDNA, with arrows showing some of the higher order oligomers. Scale bar
90nm. Bottom, gallery of picked particles. Scale bar 15nm. (C) Selected class averages of 7–10 particles per class generated from 5000 particles show
ring-shaped particles with a diameter of 126A ˚ . Scale bar 11nm.
1192 Nucleic Acids Research, 2010,Vol.38, No. 4ATPase activity is further reduced compared to
NorRGAF, consistent with the hypothesis that the
DNA-binding domain can promote oligomerisation, and
hence ATPase activity. DNA binding appears to shift the
conformation of NorRGAF to a form that favours
hexameric ring formation at physiological protein concen-
trations, thus providing the necessary ATPase activity
required for open complex formation.
The requirement for three consecutive enhancer sites
is reminiscent of the EBP-related protein TyrR, which is
proposed to bind as a dimer to three TyrR boxes, forming
a hexameric species that is active in transcriptional repres-
sion (43). Another unusual feature of the NorR–DNA
interaction is the heparin resistance of the protein–DNA
complexes, which implies that NorR makes extensive
DNA contacts, possibly forming a topologically distinct
nucleoprotein complex. Our EM data show that in the
presence of the 266bp DNA fragment carrying the three
enhancer sites, NorRGAF forms oligomeric rings,
similar to other bEBPs in their active functional states.
The precise mechanism whereby the enhancer DNA
stabilises ring formation is currently unclear. One
possible model is that the DNA wraps around the
hexameric ring, making extensive contacts that help to
stabilise it. Assuming that the diameter of the hexameric
ring assembly of the AAA+ domain is  120A ˚ (38), a
minimum of 450A ˚ (the total diameter to the centre of
duplex DNA is 120+25A ˚ )o r 130bp DNA is
required to wrap around the ring. The 66bp NorR123
oligonucleotide would therefore be insuﬃcient, consistent
with our ﬁnding that the stimulatory eﬀect of this DNA
fragment, which contains all three UAS sites, is similar
that of the 21bp oligonucleotide, which carries only a
single UAS site.
The assembly of bEBPs into at least a hexamer is nec-
essary for activation of the ATPase activity required
to drive the transition of the s
54-RNA polymerase
promoter complex from the closed to the open
DNA-melted state. Although the experiments described
here have been performed with a constitutive form of
NorR lacking the regulatory GAF domain, the ATPase
activity of wild-type NorR is also enhancer dependent,
and in addition requires the binding of NO to the
ferrous iron centre to activate the catalytic activity of
the AAA+ domain. Given that the NorR apoprotein is
fully competent for DNA binding, the three enhancers
clearly provide a scaﬀold for the assembly of a stable
heparin-resistant NorR nucleoprotein complex that is
poised at the promoter, ready to perceive the NO signal.
In contrast to other EBPs such as NtrC and DctD which
are dimeric in their inactive forms and are regulated
through control of the oligomerisation state, the activity
of wild-type NorR is apparently regulated when bound
to DNA as a higher order oligomer.
In summary, our data support a unique activation
mechanism for NorR. Three NorR dimers readily bind
to the three consecutive UAS sites. DNA binding by
NorR induces conformational changes that stimulate
hexameric ring formation. NorR then forms a hexameric
ring with extensive DNA interactions (possibly through
DNA wrapping) for increased stability. In the presence
of the NO signal, intramolecular repression of the
AAA+ domain by the GAF domain is released, activat-
ing ATPase activity and allowing the NorR hexamer to
interact with RNAP-s
54 and activate transcription.
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